Because therapeutic cancer vaccines can, in theory, eliminate tumor cells specifically with
relatively low toxicity, they have long been considered for application in repressing cancer …

Incomplete radiofrequency ablation (IRFA) triggers mild protective autophagy in residual
tumor cells and results in an immunosuppressive microenvironment. This accelerates the …

PANoptosis represents a novel type of programmed cell death (PCD) with distinctive
features that incorporate elements of pyroptosis, apoptosis, and necroptosis. PANoptosis is …

Intrinsic or acquired radioresistance remained an important challenge in the successful
management of cancer. Herein, a novel “smart” multifunctional copper‐based …

Immunosuppression by the tumor microenvironment is a pivotal factor contributing to tumor
progression and immunotherapy resistance. Priming the tumor immune microenvironment …

Cancer immunotherapy has made tremendous advancements in treating various
malignancies. The biggest hurdle to successful immunotherapy would be the …

Immunogenic cell death (ICD) is a stress-driven form of regulated cell death (RCD) in which
dying tumor cells' specific signaling pathways are activated to release damage-associated …

Radiation therapy (RT) not only can directly kill tumor cells by causing DNA double-strand
break, but also exerts anti-tumor effects through modulating local and systemic immune …

Simple Summary The field of precision oncology may benefit from the discovery of reliable
biomarkers for prognosis and prediction, which will help to tailor therapeutic treatments, thus …

Brain metastasis, characterized by poor clinical outcomes, is a devastating disease. Despite
significant mechanistic and therapeutic advances in recent years, pivotal improvements in …